We are live on ! Find out more
U

UBS Portfolio holdings

AUM $136B
1-Year Est. Return 16.36%
This Fund
S&P 500
This Quarter Est. Return
+1.89%
1 Year Est. Return
+16.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$113B
AUM Growth
+$5.56B
Cap. Flow
+$4.14B
Cap. Flow %
3.68%
Top 10 Hldgs %
14.26%
Holding
11,559
New
1,144
Increased
4,238
Reduced
4,557
Closed
1,117

Sector Composition

Rank Sector Weight
1 Energy 8.95%
2 Financials 7.03%
3 Technology 6.55%
4 Healthcare 6.54%
5 Industrials 5.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PUK icon
2751
Prudential
PUK
$36.1B
$2.03M ﹤0.01%
49,267
+42,327
+610% +$1.81M
TLI
2752
DELISTED
Western Asset Corporate Loan Fund Inc.
TLI
$2.03M ﹤0.01%
167,576
+28,649
+21% +$351K
STAA icon
2753
STAAR Surgical
STAA
$1.13B
$2.03M ﹤0.01%
108,045
+16,074
+17% +$259K
IXUS icon
2754
iShares Core MSCI Total International Stock ETF
IXUS
$57.4B
$2.03M ﹤0.01%
35,127
+3,831
+12% +$216K
SM icon
2755
SM Energy
SM
$7.11B
$2.03M ﹤0.01%
28,465
+12,305
+76% +$963K
TTEK icon
2756
Tetra Tech
TTEK
$8.7B
$2.03M ﹤0.01%
342,820
-73,330
-18% -$427K
BKF icon
2757
iShares MSCI BIC ETF
BKF
$76.8M
$2.03M ﹤0.01%
55,931
-120,831
-68% -$4.22M
CAF
2758
Morgan Stanley China A Share Fund
CAF
$329M
$2.03M ﹤0.01%
93,921
+86
+0.1% +$1.91K
FTD
2759
DELISTED
FTD Companies, Inc. Common Stock
FTD
$2.03M ﹤0.01%
63,703
+63,181
+12,104% +$2M
IONS icon
2760
Ionis Pharmaceuticals
IONS
$9.14B
$2.02M ﹤0.01%
46,834
-3,848
-8% -$187K
CVS icon
2761
CALL
CVS Health
CVS
$140B
$2.02M ﹤0.01%
27,000
-22,600
-46% -$1.6M
NGD
2762
DELISTED
New Gold Inc
NGD
$2.02M ﹤0.01%
413,637
-138,429
-25% -$799K
FRGI
2763
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$2.02M ﹤0.01%
44,225
-16,875
-28% -$794K
AMAT icon
2764
PUT
Applied Materials
AMAT
$378B
$2.01M ﹤0.01%
98,500
-11,500
-10% -$211K
FXB icon
2765
Invesco CurrencyShares British Pound Sterling Trust
FXB
$76.7M
$2.01M ﹤0.01%
12,248
+3,726
+44% +$607K
JJA
2766
DELISTED
iPath Bloomberg Agriculture Subindex Total Return ETN due October 22, 2037
JJA
$2.01M ﹤0.01%
36,853
-6,926
-16% -$345K
WTS icon
2767
Watts Water Technologies
WTS
$11.6B
$2M ﹤0.01%
34,154
-23,772
-41% -$1.38M
SXC icon
2768
SunCoke Energy
SXC
$779M
$2M ﹤0.01%
87,522
-4,468
-5% -$98.4K
SCTY
2769
PUT
DELISTED
SolarCity Corporation
SCTY
$2M ﹤0.01%
31,900
+2,000
+7% +$144K
CBRE icon
2770
CBRE Group
CBRE
$43.1B
$2M ﹤0.01%
72,808
-91,457
-56% -$2.47M
ZNGA
2771
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$2M ﹤0.01%
464,496
+13,147
+3% +$60.6K
BAC.PRL icon
2772
Bank of America Series L
BAC.PRL
$3.98B
$1.99M ﹤0.01%
1,743
+275
+19% +$311K
FPF
2773
First Trust Intermediate Duration Preferred & Income Fund
FPF
$1.08B
$1.99M ﹤0.01%
90,043
+26,156
+41% +$565K
ACN icon
2774
CALL
Accenture
ACN
$101B
$1.99M ﹤0.01%
25,000
-23,500
-48% -$1.93M
IUSV icon
2775
iShares Core S&P US Value ETF
IUSV
$27.5B
$1.99M ﹤0.01%
47,166
-3,093
-6% -$127K

Similar funds

UBS's Q1 2014 Portfolio in Review

As of Q1 2014, UBS held 11,559 positions worth $113B, up 5.2% from $107B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS deployed $4.14B of net new capital in Q1 2014, opening 1,144 new positions and adding to 4,238 existing holdings. Its largest new stake was iShares MSCI USA Quality Factor ETF: 336,642 shares worth $19M.

By sector, the portfolio is most concentrated in Energy at 9% of assets, up from 8.5% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Herc Holdings, an estimated $419M trimmed.

  • UBS's largest Q1 2014 buy was iShares MSCI USA Quality Factor ETF: 336,642 shares worth $19M.
  • UBS added most to State Street SPDR S&P 500 ETF Trust in Q1 2014, an estimated $1.61B increase.
  • UBS's biggest Q1 2014 reduction was Herc Holdings, cutting an estimated $419M.
  • UBS fully exited COLE REAL ESTATE INVESTMENTS, INC COM in Q1 2014, selling an estimated $233M.
  • UBS's ten largest holdings make up 14% of its $113B portfolio in Q1 2014.
  • UBS opened 1,144 new positions and closed 1,117 in Q1 2014.
  • UBS's portfolio value rose 5.2% quarter-over-quarter to $113B.

Based on UBS's 13F filing for Q1 2014, filed 15 May 2014.